Relationship Between SUVmax and Ki-67 Expression in Breast Cancer (original) (raw)

Relationship Between SUV_max and Ki-67 Expression in Breast Cancer

Haseki Tıp Bülteni, 2020

Is there an association between immunohistochemical parameters of breast cancer and metabolic parameters obtained with 18F-fluorodeoxyglucose PET / CT?

Bekir Tasdemir

DergiPark (Istanbul University), 2019

View PDFchevron_right

How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists

Corina Dommann-scherrer

PLoS ONE, 2012

View PDFchevron_right

External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China

Tianjie Pu

BMC Cancer

View PDFchevron_right

An inter-observer Ki67 reproducibility study applying two different assessment methods: on behalf of the Danish Scientific Committee of Pathology, Danish breast cancer cooperative group (DBCG)

Maj-lis Talman

Acta oncologica (Stockholm, Sweden), 2018

View PDFchevron_right

Impact of standardization of estrogen and progesterone receptor assays of breast cancer biopsies in Denmark

Carsten Rose

European Journal of Cancer and Clinical Oncology, 1988

View PDFchevron_right

Use of Multiparameter Tests for Identifying Women with Early Breast Cancer Who Do Not Need Adjuvant Chemotherapy?

Michael Duffy

Clinical chemistry, 2017

View PDFchevron_right

Correlation of KI-67 with Prognostic Hormone Receptor Markers in Breast Carcinoma

Joy Augustine

Global journal for research analysis, 2018

View PDFchevron_right

The Reliability of Assessment of Ki-67 Expression on Core Needle Biopsy and the Surgical Specimens of Invasive Breast Cancer: Comparison of Local Pathologists' Assessment and Central Review *#

Kazuhiko Sato

Journal of Cancer Therapy

View PDFchevron_right

Could the serial determination of Ca15.3 serum improve the diagnostic accuracy of PET/CT? Results from small population with previous breast cancer

Zora Baretta, C. Ghiotto, Giorgio Saladini, Anna Cervino, Fernando Bozza

Annals of Nuclear Medicine, 2011

View PDFchevron_right

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

Etienne Brain

Breast Cancer Research and Treatment, 2012

View PDFchevron_right

Study of Receptor Status in Carcinoma Breast Patient

Dr Shakera Ahmed

Chattagram Maa-O-Shishu Hospital Medical College Journal

View PDFchevron_right

Effect of Ki-67 assessment in the distribution of breast cancer subtypes: Evaluation in a cohort of Latin American patients

Alejandro Yabar

Molecular and Clinical Oncology, 2017

View PDFchevron_right

Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from 68Ga-RGD PET/CT and 18F-FDG PET/CT

aymen ali

European Journal of Nuclear Medicine and Molecular Imaging, 2014

View PDFchevron_right

Estrogen Receptor analyses in the Danish Breast Cancer Cooperative Group. History, methods, prognosis and clinical implications

Maj-lis Talman

Acta Oncologica, 2008

View PDFchevron_right

A Comparison of Manual and Automated Methods of Quantitation of Oestrogen/Progesterone Receptor Expression in Breast Carcinoma

Vijayashree Raghavan

Journal of Clinical and Diagnostic Research, 2015

View PDFchevron_right

Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer

Joon Jeong

PloS one, 2017

View PDFchevron_right

18F-FDG PET of Locally Invasive Breast Cancer and Association of Estrogen Receptor Status with Standardized Uptake Value: Microarray and Immunohistochemical Analysis

Joseph Osborne

Journal of Nuclear Medicine, 2010

View PDFchevron_right

Relationship between 18-FDG-PET/CT and Clinicopathological Features and Pathological Responses in Patients with Locally Advanced Breast Cancers

Naci ALDEMİR

The Eurasian Journal of Medicine, 2018

View PDFchevron_right

Interlaboratory variability of Ki67 staining in breast cancer

P. Regitnig

European Journal of Cancer, 2017

View PDFchevron_right

Standardized Assessment of Ki-67 in Breast Cancer Patients Using Virtual Slides and an Automated Analyzer in Comparison to Central/Local Pathological Assessments

Kazuhiko Sato

Journal of Cancer Therapy, 2014

View PDFchevron_right

Expression of Er, Pr, Ki-67and Her-2 in Breast Cancer Diagnosis using Archival Tissue Block from Olabisi Onabanjo Teaching Hospital Shagamu and Institute of Advance Medical Research Training Ibadan

Nosa Terry Omorodion

MOJ Biology and Medicine, 2017

View PDFchevron_right

Do multiple oestrogen receptor assays give significant additional information for the management of breast cancer?

Adele Traina

British Journal of Cancer, 1989

View PDFchevron_right

The Relationship between 18-FDG-PET/CT and Clinicopathologic Features, Pathologic Response in Patients with Locally Advanced Breast Cancer

Melih Simsek

The Eurasian Journal of Medicine

View PDFchevron_right

Old and new markers for breast cancer prognosis: the need for integrated research on quantitative issues

Elia Mario Biganzoli

European Journal of Cancer, 2004

View PDFchevron_right

Mammographic Breast Density and Breast Cancer Molecular Subtypes: The Kenyan-African Aspect

Innocent Abayo

View PDFchevron_right

The importance of SUVmax in predicting prognosis of invasive breast carcinoma-no special types

Yasar Unlu

2021

View PDFchevron_right

What is the effect of advanced diagnostic methods on sensitivity and survival in the multiple breast cancers? A systematic analysis and comparison

Nazmi Özer

Asian Journal of Medical Sciences, 2021

View PDFchevron_right

Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer

Neha Dahiya, Rodrigo Goncalves

View PDFchevron_right

Assessment of Ki67 in Breast Cancer: A Comparison Between the Eye-10 Method, Stepwise Counting Strategy, and International System of Ki67 Evaluation

Iranian Journal of Pathology, Fatemeh Aram

Iranian Journal of Pathology, 2020

View PDFchevron_right

Imaging Characteristics and Hormonal Receptor Correlations in Varieties of Breast Cancer

Enver ROSHI

International journal of biomedicine, 2024

View PDFchevron_right

Breast Cancer 2013 - Interpretation of New and Known Data

HC Kolberg

Geburtshilfe und Frauenheilkunde, 2013

View PDFchevron_right

Correlation between numerical and categorical immunohistochemical score of Ki-67 and HER2 with clinicopathological parameters of breast cancer

Suada Kuskunović-vlahovljak

Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina, 2021

View PDFchevron_right

Visual and digital assessment of Ki-67 in breast cancer tissue - a comparison of methods

Henrik Pettersen

Diagnostic Pathology, 2022

View PDFchevron_right

Relationship Between SUVmax and Ki-67 Expression in Breast Cancer (original) (raw)

Related papers